Cargando…

Biological therapy for severe asthma – Indian perspectives and challenges

Asthma is a complex and heterogeneous disease. Severe asthma makes up only a minority of asthma patients encountered in clinical settings but accounts for substantial healthcare utilisation in terms of manpower as well as economic allocation. The availability of monoclonal antibodies has a major imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venkitakrishnan, Rajesh, Augustine, Jolsana, Ramachandran, Divya, Cleetus, Melcy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298827/ https://www.ncbi.nlm.nih.gov/pubmed/37148024 http://dx.doi.org/10.4103/lungindia.lungindia_432_22

Ejemplares similares

Casirivimab - Imdevimab in Covid 19 – Early Indian experience
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2022)

Pneumothorax ex vacuo: Three cases of an uncommon entity
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2023)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence
por: Rajesh, V., et al.
Publicado: (2020)

Hospitalisation outcomes in pneumococcal-vaccinated versus -unvaccinated patients with exacerbation of COPD: results from the HOPE COPD Study
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2023)

Delayed lung function testing after COVID-19 to detect persistent lung function abnormalities – The DELTA – COVID-19 lung function study
por: Nirmal, Aparna S., et al.
Publicado: (2022)

Expecting the unexpected – Primary mediastinal large B cell lymphoma presenting as huge lung parenchymal mass
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2021)

Tuberculous cold abscess of the chest wall masquerading as unilateral apparent gynecomastia
por: Divya, R., et al.
Publicado: (2021)

COVID-19 presenting as acute transient flaccid limb paralysis
por: Rajesh, V, et al.
Publicado: (2021)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Switching Biological Therapies in Severe Asthma
por: Scioscia, Giulia, et al.
Publicado: (2023)

Biologic Therapy and Severe Asthma in Children
por: Russo, Daniele, et al.
Publicado: (2021)

Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Severe Asthma and Biological Therapies: Now and the Future
por: Sardon-Prado, Olaia, et al.
Publicado: (2023)

Novel Biological Therapies for Severe Asthma Endotypes
por: Pelaia, Corrado, et al.
Publicado: (2022)

Biological Therapy of Severe Asthma and Nasal Polyps
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
por: Lombardi, Carlo, et al.
Publicado: (2022)

The potential promise and challenge for tezepelumab as a biologic therapy for severe asthma
por: Williams, Dennis M
Publicado: (2022)

Combination of Biological Therapy in Severe Asthma: Where We Are?
por: Carriera, Lorenzo, et al.
Publicado: (2023)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

A pragmatic guide to choosing biologic therapies in severe asthma
por: Kavanagh, Joanne E., et al.
Publicado: (2021)

Severe alcoholic hepatitis: current perspectives
por: Philips, Cyriac Abby, et al.
Publicado: (2019)

Biological treatments for severe asthma
por: Jin, Hyun Jung
Publicado: (2020)

Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Biologic Therapies in Pediatric Asthma
por: Perikleous, Evanthia P., et al.
Publicado: (2022)

Molecular Targets for Biological Therapies of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2020)

An Interesting Case of Takayasu Arteritis With Acute Bilateral Pulmonary Thromboembolism
por: Augustine, Jolsana, et al.
Publicado: (2023)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Crimi, Claudia, et al.
Publicado: (2023)

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab
por: Cheng, Shih-Lung
Publicado: (2021)

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
por: Giovannini, Mattia, et al.
Publicado: (2019)

Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review)
por: Fildan, Ariadna Petronela, et al.
Publicado: (2021)

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review
por: Votto, Martina, et al.
Publicado: (2021)

Biological therapies in moderate and severe psoriasis: perspectives and certainties
por: Constantin, MM, et al.
Publicado: (2014)

Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

Challenges in the management of severe allergic asthma in the elderly
por: Ozturk, Ayse Bilge, et al.
Publicado: (2016)

Tailored therapy for severe asthma
por: Menzella, Francesco, et al.
Publicado: (2015)

Definitions of non-response and response to biological therapy for severe asthma: a systematic review
por: Khaleva, Ekaterina, et al.
Publicado: (2023)

Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence
por: Murphy, Kevin R, et al.
Publicado: (2009)

Overnutrition in Indian Children: Challenges and Opportunities
por: Ramachandran, Prema, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fe06v6mc5fu38ljmmb77dcgb37